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In the E. coli periplasm, C-terminal peptides of mis-
folded outer-membrane porins (OMPs) bind to the
PDZ domains of the trimeric DegS protease, trig-
gering cleavage of a transmembrane regulator and
transcriptional activation of stress genes. We show
that an active-site DegS mutation partially bypasses
the requirement for peptide activation and acts
synergistically with mutations that disrupt contacts
between the protease and PDZ domains. Biochem-
ical results support an allosteric model, in which
these mutations, active-site modification, and pep-
tide/substrate binding act in concert to stabilize
proteolytically active DegS. Cocrystal structures of
DegS in complex with different OMP peptides reveal
activation of the protease domain with varied confor-
mations of the PDZ domain andwithout specific con-
tacts from the bound OMP peptide. Taken together,
these results indicate that the binding of OMP pep-
tides activates proteolysis principally by relieving
inhibitory contacts between the PDZ domain and
the protease domain of DegS.
INTRODUCTION
Intracellular proteases are ubiquitous in biology, where they
function in regulatory pathways and in protein quality control.
Because of the intrinsically destructive nature of these enzymes,
their activities are usually highly regulated (Hauske et al., 2008).
For example, degradation by proteases in the HtrA family is
controlled by ligand-induced changes in enzyme conformation
(Kim and Kim, 2005). These multimeric molecular machines,
which function as trimers or higher oligomers, are widely con-
served and implicated in pathogenesis in bacteria and many
diseases in humans (Ehrmann and Clausen, 2004; Vande Walle
et al., 2008). Each HtrA subunit contains a trypsin-like protease
domain and one or two regulatory PDZ domains. How the activ-
ities of HtrA proteases are allosterically regulated is an important
question, which is just beginning to be understood for a few
family members.
Escherichia coli DegS is an HtrA-family protease that cata-
lyzes the rate-limiting activation step in the sE envelope-stress
response (for reviews, see Alba and Gross, 2004; Kim and Kim,
2005; Ades, 2008). Each DegS subunit contains one serine-
protease domain and one PDZ domain. The functional proteaseStructure 17, 1411–is a trimer, which is anchored to the periplasmic side of the inner
membrane via N-terminal sequences. Under normal conditions
of cell growth, the proteolytic activity of DegS is minimal.
However, when heat shock or other environmental stresses
disrupt protein folding in the periplasm, DegS is activated to
cleave RseA, a membrane-spanning protein whose cytoplasmic
domain binds and inhibits sE (Ades et al., 1999; Alba et al., 2002;
Grigorova et al., 2004). This initial site-1 cleavage primes intra-
membrane site-2 proteolysis of RseA by RseP (Alba et al.,
2002). After site-2 cleavage, the complex of sE with the cyto-
plasmic domain of RseA is released from the inner-membrane,
and the remaining portions of RseA in this complex are subse-
quently degraded by cytoplasmic ATP-dependent proteases
(Flynn et al., 2004; Chaba et al., 2007). The liberated sE then
binds RNA polymerase and activates transcription of specific
stress-response genes (Rhodius et al., 2006).
How is DegS activity regulated? Peptides ending with Tyr-
Xxx-Phe (YxF) bind to the DegS PDZ domain and dramatically
increase proteolytic cleavage of the RseA substrate in vitro
(Walsh et al., 2003). This C-terminal sequence motif is present
in many outer-membrane porins (OMPs), including those whose
overexpression activates DegS in vivo. Moreover, the YxF motif
is inaccessible in membrane-imbedded OMPs (Basle´ et al.,
2006), suggesting that misfolded OMPs in the periplasm activate
DegS, thereby initiating the envelope-stress response. Crystal
structures of DegS, with and without bound OMP peptides,
show that the peptide-binding site is almost 20 A˚ from the
enzyme active site, which is malformed in the peptide-free
enzyme (Wilken et al., 2004; Zeth, 2004). Thus, peptide activation
is allosteric. Biochemical experiments also indicate that satura-
tion of the enzyme with the RseA substrate and with OMP
peptides is necessary for maximal activation of DegS
(Figure 1A; Sohn and Sauer, 2009).
Two mechanisms have been proposed to explain how OMP
peptides activate DegS. The inhibition-relief model postulates
a dynamic equilibrium between inactive and active DegS confor-
mations, with peptide binding driving the equilibrium toward the
active state by disrupting inhibitory interactions mediated by the
PDZ domain (Walsh et al., 2003; Sohn et al., 2007; Sohn and
Sauer, 2009). In the peptide-activation model, by contrast,
specific contacts between the penultimate side-chain of the
PDZ-bound OMP peptide and the L3 loop of the DegS protease
domain play important roles in determining DegS activity via
changes in active-site geometry and dynamics (Wilken et al.,
2004; Hasselblatt et al., 2007). Distinguishing between these
models is important for understanding molecular mechanism
and has implications for understanding how regulation of DegS
activity has evolved, for modeling the envelope-stress response1421, October 14, 2009 ª2009 Elsevier Ltd All rights reserved 1411
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Figure 1. Allosteric Activation of DegS and
the H198P Mutant
(A) The DegS trimer equilibrates between inactive
(squares) and active conformations (circles), with
OMP-peptide and RseA-substrate binding stabi-
lizing the active enzyme. Activation involves rota-
tion of the peptide bond between His198 and
Gly199 to create a functional oxyanion hole (Wilken
et al., 2004).
(B) Activation of H198P DegS (0.2 mM trimer)
cleavage of RseA (50 mM) by the DNRDGNVYQF and
YQF peptides. The lines are fits to the equation
rate = basal + max/(1+(Kact/[peptide])
n), where
basal is the unstimulated cleavage rate, max is
the maximal cleavage rate, Kact is the activation
constant, and n is the Hill constant. Fitted param-
eters are listed in Table 1.
(C) Substrate dependence of the steady-state rate
of RseA cleavage by H198P DegS (0.2 mM trimer)
without OMP peptide, with saturating KRRKGKVYYF
peptide (60 mM), or with saturating YYF peptide
(230 mM). The lines are fits to the Hill form of the
Michaelis-Menten equation: rate = Vmax/(1+(KM/
[RseA])n). Fitted constants are listed in Table 1.in vivo, and for engineering this and related proteolytic systems
for alternative uses.
Here, we report biochemical and structural experiments that
probe DegS activation. We find that a single mutation in the
active site (H198P) partially bypasses the normal requirement
for OMP-peptide activation. When the H198P mutation is
combined with additional mutations that disrupt inhibitory inter-
actions between the PDZ domain and the protease domain, the
need for peptide activation is almost completely abolished, and
RseA binding alone stimulates the mutant to activity levels
similar to those of peptide-activated wild-type DegS. These
mutations, OMP-peptide binding, and covalent active-site modi-
fication of DegS all act in concert to stabilize the active enzyme.
Finally, we present crystal structures that reveal how the H198P
mutation stabilizes active DegS and show that specific contacts
between bound OMP peptides and the protease domain are not
required for allosteric activation of DegS.
RESULTS
The H198P Mutation Activates DegS in the Absence
and Presence of OMP Peptide
The allosteric switch between the inactive and active conforma-
tions of DegS changes the oxyanion-hole of the enzyme from
a malformed to a catalytically competent structure (Figure 1A;
Wilken et al., 2004; Zeth, 2004; Sohn et al., 2007; Hasselblatt
et al., 2007). In this switch, the His198-Gly199 peptide bond
rotates almost 180, allowing the -NH to accept a hydrogen
bond from the carbonyl oxygen of the substrate scissile peptide
bond. Residue 198 is poorly conserved in the family of HtrA
proteases. For example, proline occupies this position in DegS
homologs from Mycobacterium tuberculosis and Pseudomonas1412 Structure 17, 1411–1421, October 14, 2009 ª2009 Elsevier Ltdaeruginosa, and these proteases may be somewhat more active
than DegS in the absence of activating ligands (Mohamedmo-
haideen et al., 2008; Cezairliyan and Sauer, 2009). Thus, we
hypothesized that residue 198 might influence the conformation
of the DegS oxyanion hole.
WesubstitutedHis198withalanineorproline.TheH198Amutant
behaved like wild-type DegS in assays of RseA cleavage and
OMP-peptide stimulation (not shown). By contrast, the H198P
variant displayed properties expected if this mutation substan-
tially increases the fraction of active DegS molecules in the
absence of OMP peptide, but still results in most unliganded
enzymes assuming the inactive conformation. Multiple experi-
ments supported this conclusion. (i) In assays using sub-KM
concentrations of RseA with no OMP peptide, the H198P variant
cleaved RseA 150-fold faster than did wild-type DegS (Table 1).
This result suggests that a much higher fraction of mutant than
wild-type enzymes is active in the absence of OMP peptide. (ii)
Addition of saturating YQF OMP peptide enhanced H198P
cleavage activity by an additional factor of 20-fold (Figure 1B;
Table 1), demonstrating that most peptide-free H198P enzymes
remain in the inactive conformation. Under comparable condi-
tions of YQF saturation, the H198P mutant was also about 7-fold
more active than wild-type DegS (Table 1), suggesting that most
peptide-bound wild-type enzymes are still inactive when RseA
concentrations are low. Similar results were obtained with satu-
rating concentrations of two other OMP peptides (KRRKGKVYYF
and DNRDGNVYYF), although the degrees of stimulation varied for
each OMP peptide (Table 1). Previous studies suggest that this
disparity occurs because different OMP peptides bind active
and inactive DegS with varying affinities (Sohn and Sauer, 2009).
(iii) The OMP-peptide concentrations required for half-maximal
stimulation of activity (Kact) were lower for the H198P enzymeAll rights reserved
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OMP-Peptide Activation of the DegS Proteasethan for wild-type DegS, and the Hill coefficients for peptide acti-
vation were also slightly smaller for the mutant (Table 1). Both
results indicate that the free-energy gap between active and inac-
tive DegS is smaller for H198P than for the wild-type enzyme.
Activation by Substrate Binding
The binding of RseA substrate to wild-type DegS helps stabilize
the active enzyme (Sohn and Sauer, 2009). To address this issue
for the H198P variant, we assayed rates of RseA cleavage at
Table 1. Properties of DegS Variants in RseA Cleavage and OMP-Peptide Binding
Activation Parameters
DegS Variant OMP Peptide Maximum Activity (M1s1) Kact (mM) Hill Constant
Wild-type None 2.9 ± 0.5 n.a. n.a.
Wild-type YQF 2100 ± 200 260 ± 10 1.6 ± 0.1
Wild-type DNRDGNVYQF 590 ± 70 50 ± 5 1.6 ± 0.1
Wild-type KRRKGKVYYF 70 ± 7 %1 mM 1.2
H198P None 510 ± 70 n.a. n.a.
H198P YQF 14400 ± 2000 29 ± 5 1.3 ± 0.1
H198P DNRDGNVYQF 11400 ± 1500 4.4 ± 0.6 1.4 ± 0.1
H198P KRRKGKVYYF 10400 ± 1200 n.d.a n.d.a
H198P/K243D None 9500 ± 920 n.a. n.a.
H198P/K243D DNRDGNVYYF 12800 ± 1700 n.d.a n.d.a
H198P/D320A None 9700 ± 960 n.a. n.a.
H198P/D320A YQF 17900 ± 1200 n.d.a n.d.a
H198P/D320A DNRDGNVYYF 12300 ± 1100 n.d.a n.d.a
Michaelis-Menten Parameters
DegS Variant OMP Peptide Vmax (s
1 enz1) KM (mM) Hill Constant
Wild-type DNRDGNVYYF 1.1 ± 0.2 750 ± 120 1.6 ± 0.2
Wild-type YYF 2.6 ± 0.2 370 ± 40 1.4 ± 0.2
H198P None 1.4 ± 0.3 560 ± 40 1.6 ± 0.1
H198P YQF 2.2 ± 0.1 69 ± 3 1.2 ± 0.2
H198P YYF 2.3 ± 0.1 64 ± 3 1.3 ± 0.1
H198P DNRDGNVYYF 2.0 ± 0.2 94 ± 8 1.2 ± 0.1
H198P KRRKGKVYYF 2.0 ± 0.1 130 ± 20 1.1 ± 0.1
H198P/K243D None 1.2 ± 0.1 70 ± 5 1.2 ± 0.1
H198P/K243D DNRDGNVYYF 1.8 ± 0.2 68 ± 3 1.2 ± 0.1
H198P/D320A None 1.6 ± 0.2 110 ± 10 1 1 ± 0.1
H198P/D320A YQF 2.3 ± 0.2 61 ± 4 1.0 ± 0.1
H198P/D320A DNRDGNVYYF 2.0 ± 0.1 101 ± 2 1.1 ± 0.1
OMP Peptide Bindingb
DegS Variant KD (mM)
PDZ domain 0.6 ± 0.2
Wild-type 4.6 ± 0.3
DFP wild-type 2.0 ± 0.1
H198P 1.9 ± 0.1
DFP-H198P 0.39 ± 0.05
K243D 3.1 ± 0.4
H198P/K243D 0.68 ± 0.02
D320A 1.1 ± 0.1
H198P/D320A 0.45 ± 0.04
DFP-H198P/D320A 0.31 ± 0.03
Activation parameters were determined using sub-KM concentration of substrate by experiments like those shown in Figure 1B. Values in italics are
from Sohn and Sauer (2009). n.d., not determined; n.a., not applicable.
aComplete titration curves were not determined, but near saturation was confirmed by testing at least two peptide concentrations that differed by
a 2-fold minimum.
b The binding affinities are for the peptide fluorescein-b-alanine-KKDNRDGNYYF. Experimental values are an average of two or more independent
determinations. Errors were calculated as
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1=ðn 1ÞPn1ðvaluemeanÞ2
q
, where n is the number of independent trials.Structure 17, 1411–1421, October 14, 2009 ª2009 Elsevier Ltd All rights reserved 1413
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Figure 2. The H198P Mutation Stabilizes Active
DegS Synergistically with Other Mutations and
Active-Site Modification
(A) Substrate dependence of the steady-state rate of
RseA cleavage by H198P/D320A DegS (0.1 mM trimer)
without OMP peptide, with saturating DNRDGNVYYF pep-
tide (30 mM), or with saturating YYF peptide (130 mM).
The lines are fits to the Hill form of Michaelis-Menten
equation.
(B) Rates of rh-FP modification of wild-type, H198P DegS,
and H198P/D320A DegS without OMP peptide or with
saturating OMP peptides. The rates are normalized to an
arbitrary value of 100 for the wild-type enzyme plus
DNRDGNVYYF peptide (Sohn and Sauer, 2009). Errors
bars were calculated as
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1=ðn 1ÞPn1ðvaluemeanÞ2
q
,
where n is the number of independent trials.
(C) DegS, H198P DegS, or DFP-modified H198P DegS
binding to the OMP-peptide fluorescein-b-alanine-
KKDNRDGNYYF (30 nM) was monitored by changes in fluo-
rescence anisotropy. The data were fitted to a quadratic
equation for a 1:1 binding isotherm.
(D) Binding affinities of different DegS variants for the fluo-
rescein-b-alanine- KKDNRDGNYYF OMP peptide. Errors bars
were calculated as described above.different substrate concentrations either with or without satu-
rating OMP peptide (Figure 1C). Without peptide, high substrate
concentrations resulted in robust H198P cleavage activity, albeit
with a relatively high KM (560 mM) and a Hill constant (1.6) indic-
ative of substantial positive cooperativity. With saturating con-
centrations of different OMP peptides, Vmax for RseA cleavage
by H198P was only 40%–60% higher than without peptide,
and both the KM (64–130 mM) and Hill constants (1.1–1.3) were
lower (Table 1; Figure 1C). These results indicate that RseA
binding alone is sufficient to activate a majority of H198P
enzymes, although conversion of the peptide-free enzyme to
the active conformation is energetically more costly and thus
more cooperative than that of the peptide-bound enzyme. The
latter results are consistent with a model in which both OMP-
peptide binding and substrate binding contribute to stabilizing
the active enzyme.
Of the OMP peptides tested, saturating YYF resulted in the
highest maximal rates of RseA cleavage both for wild-type
DegS (2.6 ± 0.2 s1 enz1; Sohn and Sauer, 2009) and for the
H198P variant (2.3 ± 0.1 s1 enz1; Table 1). Because these
Vmax values are within error of each other, it is likely that the func-
tional conformations of the wild-type and mutant enzymes are
almost equally active in RseA cleavage. As a result, the observed
differences in activation by OMP peptides or RseA substrate
almost certainly arise because adopting the active conformation
is less energetically costly for the mutant than for the wild-type
enzyme.
Additivity of H198P and Other Allosteric Mutations
The D320A and K243D mutations disrupt salt bridges between
the DegS PDZ domain and protease domain and result in higher1414 Structure 17, 1411–1421, October 14, 2009 ª2009 Elsevier Ltdlevels of peptide-independent protease activity (Sohn et al.,
2007; Sohn and Sauer, 2009). When we combined H198P with
either D320A or K243D, the resulting double mutants were
even more active than H198P alone in cleaving sub-KM concen-
trations of RseA in the absence of OMP peptide (Table 1). More-
over, without peptide, the concentration of RseA required for
half-maximal cleavage by H198P/K243D DegS (70 mM) or
H198P/D320A DegS (110 mM) was substantially lower than for
H198P DegS (560 mM) (Table 1; Figure 2A), and the Hill constants
for substrate activation were significantly lower for the double
mutants (1.1–1.2) than for H198P alone (1.6). We conclude that
the fraction of active enzymes is higher for the double mutants
than for H198P in the absence of OMP peptide but is still less
than 1. In the presence of saturating concentrations of different
OMP peptides, Vmax for the double mutants was essentially the
same as for H198P alone (Table 1; Figure 2A).
Active-Site Reactivity
As an additional activity test, wemonitored reactivity with rhoda-
mine-fluorophosphate (rh-FP), which modifies Ser201 in the
active site of DegS only when the oxyanion hole is properly
formed. For example, rh-FPmodifiedwild-typeDegS at a detect-
able rate in the presence but not the absence of OMP peptides
(Sohn and Sauer, 2009). By contrast, without OMP peptides,
we observed a modest rate of rh-FP modification of H198P
DegS and a higher rate of modification of H198P/D320A DegS
(Figure 2B). The rates of rh-FP modification of both variants
were increased in the presence of OMP peptides (Figure 2B).
These results support a model in which the H198P mutation
increases the fraction of enzymes that assume the active confor-
mation in the absence of OMP peptides, and that this fraction isAll rights reserved
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OMP-Peptide Activation of the DegS ProteaseTable 2. Crystallographic Data and Refinement Statistics
OMP Peptide YQF YRF DNRDGNVYYF DNRDGNVYQF
Crystal form Form-1 Form-1 Form-2 Form-2
PDB code 3GDV 3GDU 3GDS 3GCO
Space group C2221 C2221 P213 P213
Unit cell a = 118.88 A˚ a = 117.57 A˚ a = 118.82 A˚ a = 119.41 A˚
b = 172.28 A˚ b = 171.28 A˚ b = 118.82 A˚ b = 119.41 A˚
c = 114.77 A˚ c = 111.69 A˚ c = 118.82 A˚ c = 119.41 A˚
Resolution 2.49 A˚ 2.93 A˚ 2.85 A˚ 2.80 A˚
Wavelength 0.97918 A˚ 0.97918 A˚ 1. 5418 A˚ 1.5418 A˚
Rsym 0.080 (0.24) 0.069 (0.439) 0.075 (0.54) 0.091 (0.846)
Unique reflections 39897 (3210) 22787 (2210) 13350 (1313) 14287(1415)
Completeness (%) 96.4 (79.1) 94.9 (93.5) 99.9 (99.9) 98.9 (100)
Data redundancy 4.3 (3.9) 4.0 (2.8) 9.2 (7.9) 11.6 (8.1)
I/sI 19.97 19.5 31.18 29.5
Rcryst 0.191 (0.205) 0.209 (0.271) 0.209 (0.264) 0.211 (0.273)
Rfree 0.224 (0.255) 0.231 (0.324) 0.221 (0.377) 0.239 (0.302)
Rmsd bond length (A˚) 0.005 0.003 0.004 0.003
Rmsd bond angle () 0.830 0.590 0.805 0.715
Solvent atoms 143 0 0 0
Average B value 73.7 125.2 63.3 84.6
Ramachandran favored/allowed (%) 98.2/100 97.4/100 97.0/100 96.6/100
Rsym = ShSj jIj(h) - < I(h) > j / ShSj < I(h) > , where Ij(h) is the jth reflection of index h and < I(h) > is the average intensity of all observations of I(h).
Rwork = Sh jFobs(h) – Fcalc(h)j j / Sh jFobs(h)j, calculated over the 95% of the data in the working set. Rfree equivalent to Rwork except calculated over
the 5% of the data assigned to the test set.
Numbers in parentheses represent values for the highest-resolution bin.increased further both by OMP-peptide binding and by addi-
tional activating mutations.
DFP Modification Stabilizes the Active Conformation
of DegS
OMP peptides bind preferentially to the active DegS conforma-
tion (Sohn and Sauer, 2009). Thus, peptide-binding affinity
provides an independent probe of DegS conformation, because
variants with a higher equilibrium fraction of active enzyme
should bind more tightly. Peptide affinity also provides a method
of assessing the conformational effects of active-site modifica-
tion by di-isopropylfluorophosphate (DFP). By monitoring fluo-
rescence anisotropy of a fluorescein-labeled OMP peptide, we
assayed binding at increasing concentrations of mutant and/or
DFP-modified enzymes (Table 1; Figures 2C and 2D). In each
case, the DFP-modified enzyme boundmore tightly than the cor-
responding unmodified enzyme. For example, H198P DegS
bound peptide with an affinity of 1.9 mM, whereas DFP-modified
H198P bound with an affinity of 0.39 mM. In general, the peptide
affinities mirrored results based on activity measurements, with
stronger binding being facilitated independently by the H198P,
K243D, and D320A mutations. The tightest peptide binding was
obtained using DFP-modified H198P/D320A, suggesting that
a higher fraction of this enzyme adopts the active conformation
than for any of the other variants tested.
Crystal Structures of Peptide-Bound DegS
We crystallized DFP-modified H198P/D320A DegS in space
group C2221 (form 1) or P213 (form 2) with four different OMPStructure 17, 1411–peptides. In total, we obtained two form-1 crystals (with peptides
YQF or YRF) and two form-2 crystals (with peptides DNRDGNVYQF,
or DNRDGNVYYF). In each case, we solved the structure by molec-
ular replacement. Table 2 lists crystal parameters and refinement
statistics. In the form-1 crystals, there was one DegS trimer in the
asymmetric unit. In the form-2 crystals, the asymmetric unit con-
tained one subunit, and the trimer was generated by crystal
symmetry. In our structures and the peptide-bound 1SOZ struc-
ture (Wilken et al., 2004), the core elements of the protease
domains were essentially identical to each other, with root-
mean-square deviation (rmsd) values% 0.42 A˚ for 163 Ca posi-
tions (Table 3). The structures of the trimers were also very
similar. For example, the 1SOZ trimer superimposed on our
YRF-bound trimer with an rmsd of 0.44 A˚ for 489 Ca positions.
Because our DegS variants had been treated with DFP prior to
crystallization, we expected that the active-site serine (Ser201)
would be modified. Indeed, the electron-density maps revealed
the presence of monoisopropylphosphorylserine (Mis201) in each
subunit (Figure 3). The second isopropyl group of DFP was
presumably removed by hydrolysis. The O1P oxygen of Mis201
occupied the oxyanion hole of the active site, making good
hydrogen bonds to the main-chain -NH groups of residue 199
(2.75 ± 0.05 A˚) and residue 201 (2.93 ± 0.19 A˚) and a weaker
interaction with the -NH of residue 200 (3.38 ± 0.27 A˚; Figure 3B).
DegS cleavage of RseA occurs at a Val-Ser peptide bond (Walsh
et al., 2003), and the isopropyl group of Mis201 is a proxy for the
valine side chain of the substrate in the acyl-enzyme. This
isopropyl group sits in the S1-specificity pocket of DegS, which
is formed by the side chains of Ile196, Leu218, and Ser2191421, October 14, 2009 ª2009 Elsevier Ltd All rights reserved 1415
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OMP-Peptide Activation of the DegS ProteaseTable 3. Structural Comparison of Protease Domains
3GDV_A 3GDV_B 3GDV_C 1SOZ_A 1SOZ_B 1SOZ_C 3GDU_A 3GDU_B 3GDU_C 3GDS_A 3GCO_A
Rmsd A˚ Rmsd A˚ Rmsd A˚ Rmsd A˚ Rmsd A˚ Rmsd A˚ Rmsd A˚ Rmsd A˚ Rmsd A˚ Rmsd A˚ Rmsd A˚
3GDV_A 0.00
3GDV_B 0.32 0.00
3GDV_C 0.28 0.22 0.00
1SOZ_A 0.29 0.38 0.36 0.00
1SOZ_B 0.27 0.30 0.27 0.30 0.00
1SOZ_C 0.30 0.33 0.28 0.30 0.26 0.00
3GDU_A 0.31 0.42 0.38 0.36 0.35 0.39 0.00
3GDU_B 0.41 0.28 0.33 0.41 0.37 0.39 0.39 0.00
3GDU_C 0.38 0.33 0.25 0.41 0.34 0.34 0.37 0.27 0.00
3GDS_A 0.25 0.24 0.18 0.31 0.24 0.28 0.34 0.32 0.27 0.00
3GCO_A 0.25 0.26 0.20 0.33 0.25 0.29 0.34 0.34 0.30 0.14 0.00
The core protease domains (residues 44–63, 79–133, 138–176, 190–216, and 229–250) of subunits in the 1SOZ, 3GDV, 3GDU, 3GDS, and 3GCO
crystal structures of DegS were superimposed using 163 common Ca positions.(Figure 3C). In our structures, these residues had somewhat
different conformations than seen in peptide-free DegS or in
the previously reported peptide-bound 1SOZ structure (Wilken
et al., 2004; Zeth, 2004), suggesting that the some rearrange-
ment of the S1 pocket is induced by the substrate mimic
(Figure 3C). Notably, the S1 pocket in our structures was very
similar to the corresponding region in a structure of theM. tuber-
culosis HtrA2 ortholog (rmsd = 0.4 A˚), in which a peptide
substrate was found acylated to the active-site serine (Moha-
medmohaideen et al., 2008). Thus, our DFP-modified H198P/
D320A structures mimic the substrate-bound enzyme.
Our crystal structures also suggest a mechanism by which the
pyrrolidine ring of the mutant Pro198 side chain stabilizes the
active conformation ofDegS. Aportion of thePro198 ring contacts1416 Structure 17, 1411–1421, October 14, 2009 ª2009 Elsevier Ltdthe aromatic ring of Tyr162 (Figure 3B), which is part of the LD loop
and plays an important role in allosteric activation. During this
process, the side chain and main chain of Tyr162 move from their
positions in inactive DegS, allowing the Tyr162 backbone -NH to
hydrogen bond to the main-chain carbonyl oxygen of residue
198, thereby stabilizing the functional oxyanion hole (Figure 3B;
Wilken et al., 2004). As a result, the additional packing interac-
tions between the side chains of Pro198 and Tyr162 in the H198P
mutant could easily stabilize the active conformation of DegS
relative to the inactive conformation (see Discussion).
Varied PDZ-Domain Positions
As observed in previous peptide-bound structures (Wilken et al.,
2004; Hasselblatt et al., 2007), electron density for the PDZPDZ
domain
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Figure 3. Structures
(A) Cartoon representation of the OMP-peptide
bound H198P/D320A DegS trimer (3GDV). The
protease domains of different subunits are colored
green, cyan, and magenta, except the L3 loop,
which is colored black; the PDZ domains are
colored slate blue. The YQF OMP peptide and
the modified active-site serine (Mis201) are shown
in CPK representation.
(B) Interactions near the active site of the 3GDV
structure. The O1P oxygen of Mis201 (2Fo-Fc elec-
tron density contoured at 1.6 s) accepts hydrogen
bonds from the -NH groups of the oxyanion hole.
Packing interactions between the pyrrolidine ring
of Pro198 and the aromatic ring of Tyr162 help to
stabilize the hydrogen bond between backbone
carbonyl oxygen and -NH groups of these amino
acids and therefore stabilize the functional
active site.
(C) The peptide-bound 1SOZ structure (Wilken
et al., 2004) and our peptide-bound 3GCO struc-
ture have very similar conformations near the
active site, except for the modification of Ser201
in 3CGO and the His198/Pro sequence change.
In the 3GCO structure, Leu218 and Ser219 in the
S1-specificity pocket move to some degree to
accommodate the isopropyl moiety of Mis201,
which mimics the P1 side chain of a substrate.All rights reserved
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Figure 4. Structural Variations in PDZ
Domains, L3 Loops, and OMP-Peptide
Binding
(A) After alignment of the protease domains, the
PDZ domains of different peptide-free structures
(1TE0_A; magenta) and peptide-bound structures
(1SOZ_B, cyan; 3GDV_A, yellow; 3GDV_B, green;
3GDS_A, blue) adopt somewhat different orienta-
tions. The linker that connects the protease and
PDZ domains is colored in orange, and part of
the aligned protease domain is shown in gray.
Only parts of the PDZ domains are shown for
simplicity.
(B) L3 loops assume variable conformations in the
protease domains of different peptide-free struc-
tures (1SOT_B, light orange; 1TE0_A, magenta)
and peptide-bound structures (1SOZ_B, cyan;
3GDV_A, yellow; 3GCO_A, blue). The last helix of
the protease domain in these structures is also
shown.
(C) Binding of the YQF OMP peptide (electron
density for the OMP peptide from a simulated-an-
nealing omit map is contoured at 1s) to the PDZ
domain of chain C in the 3GDV structure. The
side chain of the penultimate peptide glutamine
appears to hydrogen bond to Glu286 in the PDZ
domain.
(D) Varied side-chain conformations and contacts between OMP peptides and the L3 loop. In subunit B of the 1SOZ structure, the penultimate peptide glutamine
contacts the L3 loop and the antepenultimate tyrosine points away from the L3 loop. In subunit B of the 3GDV structure, the penultimate peptide glutaminemakes
no L3-loop contacts and the antepenultimate tyrosine is rotated approximately 90 from the 1SOZ position. This viewwas generated by aligning theOMP-peptide
backbones.domains (residues 256–355) in our structures was poorer than for
the protease domains, but we built approximately 80% of each
PDZ domain. The orientations of these PDZ domains with
respect to their attached protease domains were roughly similar
to those in prior structures (Wilken et al., 2004; Zeth, 2004; Has-
selblatt et al., 2007). Namely, the helix formed by residues 314–
325 in the PDZ domain, which forms part of the OMP-peptide
binding site, was reasonably close to parts of the L3 loop in
the protease domain and ran roughly parallel to the last helix
(residues 240–252) of the protease-domain (Figures 3A and 4A).
Nevertheless, there were significant differences in the posi-
tioning of individual PDZ domains in different subunits and struc-
tures. Some of these differences are illustrated in Figure 4A. After
superposition of the protease domains, poor alignment was
observed among PDZ domains taken from our new structures
and among PDZ domains from previously published peptide-
bound and peptide-free structures. Differences in the positions
of PDZ domains vis-a`-vis the protease domain were observed
even when the same OMP peptide was bound to this domain
and even for peptide-bound PDZ domains in different subunits
of a single crystallographic trimer. For example, comparing the
same Ca positions in different PDZ domains revealed variations
as large as 4 A˚ among our form-1 and form-2 structures,
changes of 7 A˚ between some of our structures and previous
peptide-bound structures, and movements of 10 A˚ between
the most divergent peptide-bound and peptide-free structures.
In peptide-free DegS, the PDZ domain of each subunit medi-
ates numerous polar and hydrophobic interactions with the cor-
responding protease domain, burying approximately 400 A˚2 of
surface (Wilken et al., 2004; Zeth, 2004). The peptide-binding
helix in the PDZ domain (residues 314–325; Figure 4A) makesStructure 17, 1411–many of these interactions with the protease domain. By
contrast, the PDZ domains in our different peptide-bound struc-
tures made far fewer contacts with the protease domains and
buried less surface (150 ± 60 A˚2). These peptide-mediated
changes in interactions between the PDZ domain and the L3
loop occur because of movements in both structural elements.
As observed for the PDZ domains, the L3 loops in different
subunits of peptide-bound structures also adopted varied struc-
tures (Figure 4B).
Peptide Contacts
Each OMP peptide in our structures interacted with the PDZ
domain largely as previously reported (Wilken et al., 2004).
Specifically, the peptide a-carboxylate formed hydrogen bonds
with the backbone -NH groups of residues 259 and 261 in the
PDZ domain, the OMP-peptide backbone formed an irregular
anti-parallel b sheet with PDZ residues 261–263, and the phenyl-
alanine side chain of the C-terminal residue of the peptide
packed into a deep hydrophobic pocket formed in part by resi-
dues in the 314–325 helix. However, significant differences in
peptide-binding geometry were also observed. For example,
the antepenultimate peptide tyrosine in all of our structures
adopted a different rotamer than in the 1SOZ structure, as did
the penultimate glutamine, when it was present in our structures
(Figures 4C and 4D; Wilken et al., 2004).
Combining our new structures with those determined previ-
ously provides 14 independent views of peptide-bound DegS
subunits, either in distinct crystal environments or with different
OMP peptides bound. Among these structures, molecular
contacts between the bound peptide and the protease domain
varied widely and were sometimes completely absent. In1421, October 14, 2009 ª2009 Elsevier Ltd All rights reserved 1417
Structure
OMP-Peptide Activation of the DegS Proteaseprevious structures, a contact was observed between the penul-
timate side chain of the OMP peptide and the L3 loop in the
protease domain (Wilken et al., 2004; Hasselblatt et al., 2007).
By contrast, the penultimate side chains of the OMP peptides
in our structures interacted onlywith residues in the PDZdomain.
For example, in our form-1 crystal with bound YQF peptide, the
glutamine side chain of the penultimate peptide residue interacts
with the side chain of Glu286 in the PDZ domain. In a subset of our
structures, contacts were seen between the antepenultimate
peptide side chain and the L3 loop of the protease domain, but
these interactions were highly variable.
DISCUSSION
Active DegS Structures
We were unable to obtain crystals of wild-type DegS in complex
with OMP peptides, perhaps because wild-type DegS is largely
in the inactive conformation even with saturating OMP peptide
(Sohn and Sauer, 2009). By contrast, in trials using the DFP-
modified H198P/D320A mutant, which is predominantly in the
active conformation, crystals with OMP peptides were obtained
under many different conditions, and four structures were
solved. There are now a total of six peptide-bound DegS struc-
tures in different space groups or with different OMP peptides.
Our new structures are of mutant proteins, whereas previous
structures used a variant of ‘‘wild-type’’ DegS (Wilken et al.,
2004; Hasselblatt et al., 2007). However, both peptide-bound
wild-type structures crystallized in the same lattice as the inac-
tive peptide-free enzyme, raising potential concerns about the
influence of crystal packing on conformation. These wild-type
DegS variants also lacked some N-terminal sequences that
appear to stabilize the DegS trimer in our structures. In our
view, the ensemble of structures provides the most accurate
view of the conformational properties of DegS in the peptide-
bound active structure.
In all of the peptide-boundDegS structures, the conformations
of the core elements of the protease domain are essentially the
same, and the oxyanion hole is properly formed. Indeed, in our
new structures, an oxygen atom from the modified active-site
serine mimics part of a substrate and accepts hydrogen bonds
from the -NHgroups of the oxyanion hole. The same core confor-
mation of the protease domain is also observed in crystal struc-
tures of DegS lacking its PDZ domain (Hasselblatt et al., 2007;
Sohn et al., 2007). Indeed, significant conformational differences
in the protease domains of all of these structures are only
observed in the LA, L2, and L3 loops, which are partially disor-
dered in many subunits. Moreover, when these loops are fully
ordered, they often make crystal-packing contacts.
The PDZ domains in all known ‘‘active’’ DegS structures have
main-chain B-factors that are on average approximately twice
those of the protease domains. Moreover, only 40%–85% of
the PDZ residues are included in the models of different struc-
tures. The conformations of these structured parts and the
mode of OMP-peptide binding are generally similar for different
PDZ domains, but the orientations of the PDZ domains with
respect to the attached protease domain differ substantially.
As a consequence, wide variations are observed in contacts
between the bound OMP peptides and the protease domains.
In previous structures, contacts between the penultimate side1418 Structure 17, 1411–1421, October 14, 2009 ª2009 Elsevier Ltdchain of theOMPpeptide and the L3 loop of the protease domain
were observed (Wilken et al., 2004; Hasselblatt et al., 2007).
Such interactions with the protease domain are absent in all of
our structures, in which the penultimate side chain of the OMP
peptide contacts the PDZ domain only. Indeed, when all of the
peptide-bound structures are included, there are no conserved
contacts between the OMP peptide and the protease domain
and, in some cases, there are no interactions of any kind
between these elements. Taken together, these observations
suggest that the PDZ domains and bound OMP peptides in
active DegS are only loosely tethered to the protease domains,
with their exact orientations and contacts being determined
predominantly by crystal packing. There is one structure of
a peptide-bound DegS homolog, M. tuberculosis HtrA2 (Moha-
medmohaideen et al., 2008). As in our DegS structures, no
contacts are observed between the penultimate residue of the
bound peptide and the protease domain in this HtrA2 structure.
Implications for Mechanisms of Allosteric Activation
There are two models for how OMP-peptide binding activates
DegS. The inhibition-relief model posits that peptide binding
breaks inhibitory interactions mediated by the PDZ domain,
thereby shifting a dynamic equilibrium away from inactive
DegS and toward the active enzyme (Walsh et al., 2003; Sohn
et al., 2007; Sohn and Sauer, 2009). The peptide-activation
model proposes that specific interactions between the penulti-
mate side chain of the bound OMP peptide and the L3 loop of
the protease domain are responsible for setting the precise level
of DegS activity (Wilken et al., 2004). Themost recent variation of
this model states that ‘‘different activating peptides induce
different rearrangements of loop L3, which have a different effect
on the active site geometry and rigidity’’ (Hasselblatt et al., 2007).
Thus, the first model proposes that there are two basic confor-
mations of DegS, active and inactive, whereas the secondmodel
envisions a variety of functional conformations, each with a
different activity (Figure 5).
Evidence supporting a peptide-activation-only model is weak.
For example, contacts between the penultimate side chain of the
PDZ-bound OMP peptide and the L3 loops vary within a given
trimer in previously published structures and are absent in the
structures reported here. Moreover, dramatic changes in the
identity of the penultimate OMP-peptide residue result in only
small changes inDegSactivity (±15%fromaverage) under condi-
tions of peptide saturation (Sohn et al., 2007). Hence, contacts
mediated by the penultimate side chain of the OMP peptide
may have a 30% influence on DegS activity, but these effects
are very small compared with effects at other peptide positions
(up to 35-fold) and to the maximal levels of OMP-peptide activa-
tion of DegS (850-fold or greater; Sohn and Sauer, 2009).
How strong is the evidence for the inhibition-relief model? In
this two-state equilibrium model, the unliganded enzyme is
largely inactive because contacts between the PDZ domain
and the protease domain stabilize inactive DegS. Preferential
binding of OMP peptides and RseA substrate to active DegS
then drive the equilibrium population toward this species (Sohn
et al., 2007; Sohn and Sauer, 2009). As a consequence, any
mutation that destabilizes inactive DegS or that stabilizes active
DegS should result in higher peptide-independent activity. Both
results are observed. The D320A and K243D mutations, whichAll rights reserved
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domains, activate DegS (Sohn et al., 2007; Sohn and Sauer,
2009). As we have shown here, so does the H198P mutant,
which makes additional stabilizing interactions in the active
conformation. Combining either D320A or K243Dwith H198P re-
sulted in double mutants that cleaved low concentrations of
RseA 20-fold to 100-fold faster than the single mutants in the
absence of OMP peptides. In fact, subsequent addition of satu-
rating OMP peptides stimulated the protease activity of the
double mutants less than 2-fold. Synergy was also observed in
OMP-peptide binding, which was stronger for the H198P/
D320A or H198P/K243D double mutants than for the single
mutants and stronger for DFP-modified H198P and the double
mutants than for the unmodified enzymes. Thus, mutations/
modifications that stabilize the active enzyme or that destabilize
the inactive enzyme have additive effects, as expected for a two-
state allosteric model.
The inhibition-relief model obeys the rules of MWC allostery
(Monod et al., 1965). Thus, activity can be predicted from the
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Figure 5. Models for DegS Activation
(A) The inhibition-relief model posits an equilibrium between free inactive
trimers (open squares) and free active trimers (open circles). OMP peptides
bind to both states (shaded circles or squares) and shift the equilibrium toward
the active form because they bind more tightly to this conformation than the
inactive conformation.
(B) The peptide-activation model posits that different OMP peptides stabilize
slightly different DegS conformations, in which the precise activity depends
on the identity of the penultimate side-chain of the bound peptide.Structure 17, 1411–equilibrium constant that relates the unliganded inactive and
active species and from the concentrations and affinities of
OMP peptide and substrate for both enzyme conformations.
Previously, we showed that the experimental behavior of
numerous variants of DegS with multiple OMP peptides could
be reproduced quantitatively using the MWC model (Sohn and
Sauer, 2009). For example, saturating concentrations of different
OMP peptides activate DegS to very different maximal levels,
which the inhibition-relief model explains by affinity-driven
changes in the equilibrium distribution of active and inactive
enzymes with bound peptide (Figure 5A). By contrast, the
peptide-activation model explains such differences in peptide
activity by changes in the conformation or dynamics of the func-
tional enzyme (Figure 5B). The inhibition-relief model explains
why the cooperativity of activation changes for different pep-
tides, how different peptides change Vmax and KM for substrate
cleavage, and why peptides, which activate wild-type DegS
poorly, can be much better activators of mutants in which the
inactive conformation is destabilized. The peptide-activation
model cannot explain many of these results or can only account
for them in an ad hocmanner. Onemight argue that the observa-
tion of variable peptide-bound PDZ domain orientations and
modest differences in protease-domain loop conformations in
different crystal structures of active DegS argues against a strict
two-state model. However, OMP-peptide binding in the inhibi-
tion-relief model serves only to break restraining contacts, and
thus a specific active conformation of the peptide-bound PDZ
domain is not required. More importantly, if the observed varia-
tions in structure are nearly isoenergetic, then the systemwill still
behave in a two-state fashion.
The H198P Mutation and Allosteric Activation
The H198P mutation appears to shift the allosteric equilibrium
toward the active enzyme. Compared with wild-type DegS, for
example, H198P DegS shows a much higher RseA cleavage
rate without OMP peptides, binds activating peptides more
tightly, and displays smaller Hill coefficients for substrate and
OMP peptides. Modification of the active-site serine by covalent
inhibitors also occurs at a faster rate for the H198P mutant than
for wild-type DegS.
For wild-type DegS, the equilibrium ratio of the inactive to
active conformations is about 15,000:1 in the absence of
OMP peptide and substrate, corresponding to a free-energy
difference of approximately 6 kcal/mol (Sohn and Sauer, 2009).
Fitting of the H198P experimental data to equations for MWC
allostery gave an equilibrium ratio of unliganded inactive to
active species of 22:1, corresponding to a free energy difference
of roughly 2 kcal/mol (not shown). This reduction predicts that
even modest stabilization via OMP peptide and/or substrate
binding should now be sufficient to shift the equilibrium so that
active H198P species predominate. Indeed, we observed that
high concentrations of the RseA substrate alone were able to
activate H198P DegS to levels about 60% of those achieved
with the best OMP-peptide activation. By contrast, for wild-
type DegS, cleavage of high concentrations of RseA in the
absence of OMP peptide occurs at a rate less than 0.3% of
the peptide-stimulated value.
How does the H198P mutation increase the equilibrium frac-
tion of active DegS? In our crystal structures, the pyrrolidine1421, October 14, 2009 ª2009 Elsevier Ltd All rights reserved 1419
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(Figure 3B). Specifically, the Cg andCd prolinemethylene groups
make numerous van der Waals contacts with the tyrosine ring.
These interactions were absent when we modeled Pro198 into
inactive DegS and corresponding contacts made by His198 are
absent in both active and inactive wild-type DegS (Wilken
et al., 2004; Zeth, 2004). Allosteric activation of DegS involves
movement of Tyr162 to allow its main-chain -NH to hydrogen
bond to the carbonyl oxygen of residue 198. This interaction, in
turn, locks the main-chain -NH of Gly199 into the functional oxy-
anion-hole conformation. Thus, the extra packing interactions
between Pro198 and Tyr162 should stabilize active DegS relative
to inactive DegS. To account quantitatively for the 4 kcal/mol
shift in favor of the active conformation of H198P, the new van
der Waals interactions mediated by Pro198 would need to stabi-
lize each active subunit of the trimer by approximately 1.3 kcal/
mol relative to each inactive subunit.
Allosteric activation mediated by ligand binding requires DegS
to adopt alternative inactive and active structures with an energy
gap large enough to keep the unliganded protease predomi-
nantly in the inactive state. Different orthologs probably use
diverse types of interactions to stabilize the inactive state, but
the structures of the active protease domains of these enzymes
must be constrained by the need to bind substrate and catalyze
peptide-bond cleavage.We anticipate that other members of the
HtrA-protease family will share this ligand-mediated regulatory
mechanism. From a biological and evolutionary perspective,
this relief of inhibition mechanism is highly robust because it
allows DegS function to be tuned to any desired level of frac-
tional activity simply by evolving OMP peptides with appropriate
affinities for the active and inactive enzyme conformations.
EXPERIMENTAL PROCEDURES
Proteins and Peptides
Wild-type and mutant variants of E. coli DegS (residues 27–355) contained an
N-terminal His6 tag and lacked the membrane anchor. Mutations were gener-
ated by the QuikChange method (Stratagene) and confirmed by DNA
sequencing. DegS variants and a 35S-labeled variant of the periplasmic
domain of E. coli RseA (residues 121–216) with a C-terminal His6 tag were ex-
pressed, purified, and stored as described elsewhere (Walsh et al., 2003; Sohn
et al., 2007; Sohn and Sauer, 2009). All DegS variants eluted as trimers in the
gel-filtration step of purification (Superdex 200). Peptides were synthesized by
the MIT Biopolymer Laboratory, purified by high-pressure liquid chromatog-
raphy, and their expected molecular mass was confirmed by matrix-assisted
laser desorption/ionization time-of-flight mass spectrometry.
Enzymatic and Biochemical Assays
All assays were performed at room temperature (23C ± 1C) using conditions
described previously (Sohn et al., 2007; Sohn and Sauer, 2009). For cleavage
assays, 35S-RseA was incubated with DegS or mutants for different times, and
acid-soluble radioactivity was quantified by scintillation counting. The binding
of DegS or mutant variants to a fluorescent OMP peptide was assayed by
monitoring changes in fluorescence anisotropy (excitation 480 nm; emission
520 nm), after correction for protein scattering. DFP modification of wild-
type DegS was performed with saturating OMP peptide. No peptide was
needed for full modification of the H198P and H198P/D320A mutants. OMP
peptides and/or unincorporated DFP were removed by Ni-NTA chromatog-
raphy and dialysis. All of the DFP-modified enzymes showed no detectable
RseA cleavage. Binding curves, Michaelis-Menten curves, and peptide-acti-
vation curves were fitted to appropriate equations using the nonlinear least-
squares subroutine in KaleidaGraph (Synergy software). Rh-FP (Liu et al.,
1999) was a gift fromC. Salisbury, E.Weerapana, and B. Cravatt (Scripps Insti-1420 Structure 17, 1411–1421, October 14, 2009 ª2009 Elsevier Ltdtute). Modification of DegS or variants (0.9 mM trimer) with rhodamine-FP
(20 mM) was performed in the presence or absence of OMP peptides as
described (Sohn and Sauer, 2009).
Crystallization
H198P/D320A DegS (150 mM trimer) was incubated with 20 mM DFP at room
temperature for 2 hr, 20 mM fresh DFP was added, incubation was continued
overnight, and the mixture was dialyzed against 50 mM HEPES (pH 7.4),
100 mMNaCl. A 2-fold molar excess of OMP peptide was added prior to initial
robotic high-throughput crystallization trials using Index screen (Hampton
Research), ProComplex, PACT suite (QIAGEN), and JCSG+Suite (QIAGEN).
Several crystal hits were obtained within one week at 20C. Form-1 crystals
grew with 4% PEG-6000, 150 mM MgCl2, and 100 mM Tris (pH 6.0). Form-2
crystals grew with 3% PEG-3350, 150 mMNaF, and 100 mM Bis-Tris propane
(pH 6.5). For cryo-protection, an equal volume of 40% MPD in well solution
was added to the drop just prior to freezing in liquid nitrogen. Diffraction
data for two form-1 crystals were collected at the NE-CAT 24-ID-C beamline
at the Argonne National Labs Advanced Photon Source. Form-2 crystal data
were collected in house using a Rigaku MicroMax008-HP rotating source.
Initial phases were obtained bymolecular replacement using PHASER (Storoni
et al., 2004) and the peptide-free DegS (1SOT, 1TE0) and/or DegS-DPDZ (2QF)
structures as search models. Positive electron density for OMP peptides was
observed in the initial molecular-replacement maps. Final structures were
refined by reiterative model building using COOT (Emsley and Cowtan,
2004) and refinement using PHENIX (Adams et al., 2002). Peptide positions
in the final structures were confirmed by simulated-annealing omit maps.
ACCESSION NUMBERS
Structures of the DegS protease in complex with OMP peptides have been
deposited in the Protein Data Bank with the accession codes 3GDV, 3GDU,
3GDS, and 3GCO.
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